Sleep-disordered breathing in patients with implanted cardiac devices: assessment of the change in sensitivity to carbon dioxide with cardiac resynchronisation therapy - an observational case-controlled study

Royal Brompton & Harefield NHS Trust (UK)0 个研究点目标入组 40 人开始时间: 2014年6月25日最近更新: 2020年11月16日

适应症

试验速览

暂无简介。

•1. Heart failure (of any aetiology) and a reduced ejection fraction (<40%) due to undergo implantation of a Boston Scientific biventricular pacemaker or defibrillator with the ApneaScan function
•2. They must meet UK guidelines for biventricular pacemaker implantation
•3. They should be on optimal medical therapy for heart failure
•4. They must be aged 18 or over and be able to give valid written consent for this study
•5. They must be ambulatory
•Target Gender: Male & Female; Upper Age Limit 100 years ; Lower Age Limit 18 years

•1. Patients receiving pacemakers without the ApneaScan function
•2. Patients unable or unwilling to attend follow-up testing
•3. Patients receiving devices for indications other than heart failure with reduced ejection fraction
•4. Patients with obstructive sleep apnea already on continuous positive airway pressure (CPAP) therapy
•5. Patients unable to walk

发起方

Royal Brompton & Harefield NHS Trust (UK)